e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prolidase deficiency: a new genetic cause of combined pulmonary fibrosis and emphysema syndrome in the adult
Vincent Cottin, Mouhamad Nasser, Julie Traclet, Lara Chalabreysse, Anne-Sophie Lèbre, Salim Si-Mohamed, François Philit, Françoise Thivolet-Béjui
Source:
Eur Respir J, 55 (4) 1901952; 10.1183/13993003.01952-2019
Journal Issue:
April
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Vincent Cottin, Mouhamad Nasser, Julie Traclet, Lara Chalabreysse, Anne-Sophie Lèbre, Salim Si-Mohamed, François Philit, Françoise Thivolet-Béjui. Prolidase deficiency: a new genetic cause of combined pulmonary fibrosis and emphysema syndrome in the adult. Eur Respir J, 55 (4) 1901952; 10.1183/13993003.01952-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations
Source: Eur Respir J 2014; 43: 638-641
Year: 2013
Genetic susceptibility and pulmonary fibrosis
Source: Annual Congress 2005 - Idiopathic pulmonary fibrosis: new concepts in its pathogenesis and management
Year: 2005
Novel rare genetic variants in idiopathic pulmonary fibrosis
Source: Eur Respir J, 56 (6) 2003252; 10.1183/13993003.03252-2020
Year: 2020
The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018
Year: 2018
The genetic basis of idiopathic pulmonary fibrosis
Source: Eur Respir J 2015; 45: 1717-1727
Year: 2015
Combined idiopathic pulmonary fibrosis and emphysema: functional characterization
Source: Eur Respir J 2004; 24: Suppl. 48, 283s
Year: 2004
Combined fibrosis and emphysema syndrome
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019
Combined fibrosis and emphysema syndrome
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2018
Combined fibrosis and emphysema syndrome
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019
Lung abnormalities in marfan syndrome: a pathogenetic model of early-onset emphysema?
Source: Annual Congress 2009 - Respiratory physiology
Year: 2009
Combined pulmonary fibrosis and emphysema syndrome (CFPE)
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012
Lung involvement distinct from pulmonary hypertension: a new feature of POEMS syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 371s
Year: 2002
A prothrombotic state is associated with increased mortality in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin
Source: Eur Respir J 2001; 18: 17S-29S
Year: 2001
Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?
Source: Eur Respir J 2007; 30: 835-839
Year: 2007
The ratio AGE/RAGE is increased in idiopathic pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Combined pulmonary fibrosis and emphysema: A distinct entity?
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Down syndrome and pulmonary hemosiderosis: an under-recognized association
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018
Alpha-1-antitrypsin deficiency
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=139
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept